Hepatitis B surface antigen (HBsAg) prevalence in Maldives

Maldives: Hepatitis B surface antigen (HBsAg) prevalence was 0.2% in 2024. ▼ Falling

Latest (2024)
0.2%
Change on year
unchanged
World rank
82nd
of 194 countries
All-time high
0.5%
in 2015
All-time low
0.2%
in 2021
Years of data
10
2015–2024

Hepatitis B surface antigen (HBsAg) prevalence in Maldives, 2015–2024

00.10.20.30.40.52015201920242015: 0.52016: 0.52017: 0.42018: 0.32019: 0.32020: 0.32021: 0.22022: 0.22023: 0.22024: 0.2

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Maldives is 0.2%, measured in 2024. That is the lowest value across all 10 years on record.

The figure is down 60.0% over ten years.

Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Maldives peaked at 0.5% in 2015 and was at its lowest, 0.2%, in 2021.

Maldives ranks 82nd of 194 countries on this measure, in the middle of the range.

Hepatitis B surface antigen (HBsAg) prevalence in Maldives, year by year

Annual values for Hepatitis B surface antigen (HBsAg) prevalence (%) in Maldives, 2015 to 2024.
Year Value Change
2015 0.5%
2016 0.5% +0.0%
2017 0.4% -20.0%
2018 0.3% -25.0%
2019 0.3% +0.0%
2020 0.3% +0.0%
2021 0.2% -33.3%
2022 0.2% +0.0%
2023 0.2% +0.0%
2024 0.2% +0.0%

Averages by decade

DecadeAverage LowestHighest Years
2010s 0.4% 0.3% 0.5% 5
2020s 0.2% 0.2% 0.3% 5

Countries ranked near Maldives

  1. 82 Tajikistan 0.2% compare
  2. 82 Saint Vincent and the Grenadines 0.2% compare
  3. 82 Venezuela, Bolivarian Republic of 0.2% compare
  4. 82 Antigua and Barbuda 0.2% compare
  5. 82 Bahamas 0.2% compare
  6. 82 Barbados 0.2% compare
  7. 82 Dominica 0.2% compare
  8. 82 Fiji 0.2% compare
  9. 82 Grenada 0.2% compare
  10. 82 India 0.2% compare
  11. 82 Jamaica 0.2% compare
  12. 82 Kazakhstan 0.2% compare
  13. 82 Saint Kitts and Nevis 0.2% compare
  14. 82 Libya 0.2% compare
  15. 82 Saint Lucia 0.2% compare
  16. 82 North Macedonia 0.2% compare
  17. 82 Nepal 0.2% compare
  18. 82 Pakistan 0.2% compare

See the full ranking of 202 places →

More health data for Maldives

All data for Maldives →

Frequently asked questions

What is hepatitis b surface antigen (hbsag) prevalence in Maldives?
Hepatitis b surface antigen (hbsag) prevalence in Maldives was 0.2% in 2024, according to World Health Organization, Global Health Observatory.
What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Maldives?
The highest recorded value was 0.5% in 2015.
What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Maldives?
The lowest recorded value was 0.2% in 2021.
How does Maldives rank for hepatitis b surface antigen (hbsag) prevalence?
Maldives ranks 82nd out of 194 countries with data for 2024.
Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Maldives?
Over the last ten years it is down 60.0%. The long-run trend across the full record is falling.
Where does this Maldives data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Hepatitis B surface antigen (HBsAg) prevalence in Maldives. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 22 August 2026, from https://health.statizoid.com/stat/hepatitis-b-surface-antigen-hbsag-prevalence-percent/maldives/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/hepatitis-b-surface-antigen-hbsag-prevalence-percent/maldives/">Hepatitis B surface antigen (HBsAg) prevalence in Maldives</a> — Statizoid

About this data

Indicator
Hepatitis B surface antigen (HBsAg) prevalence (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
202 places, 2,020 data points, 2015–2024
Last refreshed